Global Leukemia Academy

Webinar on Recent Updates in Pediatric and AYA ALL


Aptitude Health organized a webinar on recent updates in pediatric and AYA ALL, which included information from major conferences, as well as recent publications.

Experts shared their insights on enactment of new paradigms, including administration of new treatments such as bispecifics and patient monitoring and management. They also discussed strategic implementation of minimal residual disease (MRD) monitoring.

Date and Location

4 September 2020
3.00 pm – 4.00 pm EDT (Eastern Daylight Time)/
4.00 pm – 5.00 pm BRT (Brasilia Time)/
21.00 – 22.00 CET (Central European Time)
Virtual Meeting

Meeting Content

View the slides and watch the video of the webinar
on Recent Updates in Pediatric and AYA ALL

Ask your questions directly to the experts and receive their personal insights on current and novel treatment approaches for pediatric and adult patients with acute leukemias.


Patrick Brown

Patrick A. Brown, MD

Johns Hopkins University
School of Medicine, USA

Rupert Handgretinger

Rupert Handgretinger, MD, PhD

Children’s University Hospital and
Department of Hematology/Oncology,

Franco Locatelli

Franco Locatelli, MD, PhD

University of Rome
IRCCS Ospedale Pediatrico
Bambino Gesù, Italy


This meeting was a 1-hour virtual event.
  Time, EDT Topic Presenter
  3.00 PM – 3.05 PM/
(5 min)
Welcome and Introductions Rupert Handgretinger, MD
  3.05 PM – 3.15 PM/
(10 min)
Current Paradigm and Long-term Toxicities for Pediatric ALL
• Integration of innovative immunotherapies
• Role of MRD in treatment
• Long-term toxicities
Franco Locatelli, MD, PhD
  3.15 PM – 3.30 PM/
(15 min)
Bispecifics for Pediatric/AYA ALL
• Review of trial results in pediatric/AYA ALL
• Role of MRD in research and treatment
• AYA considerations
Patrick Brown, MD
  3.30 PM – 3.40 PM/
(10 min)
CAR T-cells for Pediatric/AYA ALL
• Benefits and risks of CAR Ts and bispecifics
• Role of MRD in research and treatment
• AYA considerations
Franco Locatelli, MD, PhD
  3.40 PM – 4.00 PM/
(20 min)
Questions to Experts Rupert Handgretinger, MD